If you or a loved one experienced aortic aneurysm, aortic dissection or died while taking a fluoroquinolone or within 60 days of discontinuing a fluoroquinolone, you may be eligible for compensation.
Fluoroquinolone drugs that may qualify include:
The FDA has warned that fluoroquinolone antibiotics like Cipro, Avelox, and Levaquin may double the risk of aortic aneurysm in certain patients. Manufacturers of these drugs may be facing a number of lawsuits for aortic injuries and other risks like tendon rupture.
Fluoroquinolone Antibiotics Lawsuit
A new safety alert issued by the U.S. Food and Drug Administration (FDA) has warned that use of fluoroquinolone or “floxin” antibiotics can double the risk of a potentially fatal medical condition, aortic aneurysm.
|Levaquin||levofloxacin||Janssen / Johnson & Johnson|
|Noroxin||norfloxacin||Merck & Co|
|Floxin||ofloxacin||Daiichi Sankyo / Johnson & Johnson|
A recent study suggests that the increased aortic aneurysm risk begins right after taking the medication and may last as long as 60 days after discontinuing it. Though the overall threat for aortic aneurysm is low, in some patients, the risks of using the antibiotics may be greater than any benefit and experts have warned that alternative therapy should be considered.Manufacturers of the drugs have already faced thousands of lawsuits for tendon rupture, aortic dissection and aneurysm, and other injuries but may be facing an increased number of lawsuits for aortic aneurysm due to the new warning.
Patients who are at greatest risk include those with a history of:
- blocked blood vessels
- high blood pressure
- Marfan syndrome, Ehlers-Danos syndrome or other genetic conditions
Previously, fluoroquinolone manufacturers have been the subject of thousands of lawsuits for tendon injury and other collagen disorders. Many of these lawsuits were previously settled for undisclosed amounts.
Fluoroquinolone Side Effects
Fluoroquinolone antibiotics work by inhibiting bacterial DNA formation and repair and preventing bacteria from dividing. They have been used to treat a wide variety of infections caused by bacteria.
Most side effects of fluoroquinolones are mild to moderate including:
- Nausea and vomiting
More severe side effects may include:
- Symptoms of allergic reaction including rash, facial swelling or difficulty breathing
- Watery diarrhea
- Changes in color of skin, urine or stool
- Swelling or fluid collection
- Changes in heart rhythm
- Tingling or unusual or sudden pain
- Confusion or unusual behavior
- Severe nervousness or anxiety
- Sudden dizziness or fainting
Severe side effects should be reported to a medical professional as soon as possible. Sudden changes or worsening condition may warrant emergency treatment.
Fluoroquinolone Aortic Aneurysm
Fluoroquinolones have been shown to increase the risk of fatal cardiac complications including aortic aneurysm and aortic dissection. This likely occurs in the same way that tendon damage occurs due to disruption of collagen formation and cartilage destruction.
The aorta is the largest blood vessel in the circulatory system and carries oxygenated blood from the heart to the tissues. It is a rigid vessel which is formed and supported by collagen. When collagen is weakened, the aorta wall may thin and bulge or tear.
Aortic aneurysm occurs when a bulge develops in the aorta. Aortic dissection occurs when a tear develops in the inner lining which then splits away from the middle layer. In either case, the aorta will rupture and cause a massive hemorrhage or blood loss, quickly resulting in death.
Fluoroquinolone FDA Warnings
In 2008, the FDA issued a” black box warning” regarding the dangers of fluoroquinolones and tendon rupture. A black box warning is the strongest warning that can be issued by the agency and must be printed at the top of prescribing information.
In 2015, an FDA advisory committee recommended that fluoroquinolones not be used as first choice medications for uncomplicated urinary tract infections, sinus infections or bronchitis. It was also recommended that use be restricted in children. In 2016, prescribing information was changed to state that fluoroquinolones should be reserved for patients who were not treatable with other medications. Information about nerve damage was also added to the patient information guide.
In December of 2018, the FDA issued a new safety warning stating that fluoroquinolone use could double the risk of aortic aneurysm, and that the medication should not be used in sensitive populations who may be at greater risk for the condition. The agency recommended again that it be reserved for patients and infections that were not treatable with other medications.
When do I need a Fluoroquinolone Lawyer?
Manufacturers of quinolone antibiotics like Levaquin, Cipro, and Avelox, have faced thousands of lawsuits for injuries caused by their medications. Many of these lawsuits were settled in previous years but the new announcement by the FDA may indicate that new lawsuits can be expected.
Fluoroquinolone drugs that may qualify include:
Past medical injury lawsuits have provided compensation for medical costs, lost wages, pain and suffering and in some case, punitive damages. There are no guarantees and each case must be evaluated separately by a legal expert.